J Korean Diabetes.  2013 Mar;14(1):11-14.

The Epidemiology of Diabetic Nephropathy

• Kim JH

Abstract

Diabetic nephropathy, the leading cause of chronic kidney disease, is a common and morbid complication of diabetes. Individuals with nephropathy are at a much greater risk for other micro- and macrovascular complications of diabetes. End-stage renal disease (ESRD) from diabetes is the most common single cause of entry to renal replacement programs worldwide. ESRD is devastating to the individual and of enormous financial and social consequences to society. Increasing diabetes prevalence is already being reflected in high diabetic nephropathy prevalence. The early detection and effective management of diabetic nephropathy would delay or prevent the progression of chronic kidney disease. Thus, it is important to understand the exact current status of diabetic nephropathy. We review the epidemiology of diabetic nephropathy including prevalence, incidence, and trends.

Keyword

Diabetic nephropathies; Epidemiology; Prevalence

MeSH Terms

Diabetic Nephropathies
Incidence
Kidney Failure, Chronic
Prevalence
Renal Insufficiency, Chronic

Reference

1. SInternational Diabetes Federation. Diabetes Atlas. 4th ed.Brussels: International Diabetes Federation;2009.

2. SKim SG, Choi DS. The present state of diabetes mellitus in Korea. J Korean Med Assoc. 2008; 51:791–8.

3. SLee KW. Outcome research in diabetes. J Korean Diabetes. 2011; 12:2–5.

4. SMogensen CE, Cooper ME. Diabetic renal disease: from recent studies to improved clinical practice. Diabetes Med. 2004; 21:4–17.

5. SParving HH. Diabetic nephropathy: prevention and treatment. Kidney Int. 2001; 60:2041–55.

6. SLee SW, Kim YC, Oh SW, Koo HS, Na KY, Chae DW, Kim S, Chin HJ. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant. 2011; 26:3975–80.

7. SUnited States Renal Data System. USRDS 2011 annual data: atlas of chronic kidney disease and end-stage renal disease in the United states. Bethesda: National Institutes of Health, National Insititute of Diabetes and Digestive and Kidney Diseases;2011.

8. SJin DC. Current status of dialysis therapy in Korea. Korean J Intern Med. 2011; 26:123–31.

9. SSuh MR, Lee EB, Yang WS, Kim SB, Park SK, Lee SK, Park JS, Hong CD. Survival analysis of hemodialysis patients-a single center study. Korean J Nephrol. 2002; 21:636–44.

10. SRaymond NT, Paul O'Hare J, Bellary S, Kumar S, Jones A, Barnett AH. UKADS Study Group. Comparative risk of microalbuminuria and proteinuria in UK residents of south Asian and white European ethnic background with type 2 diabetes: a report from UKADS. Curr Med Res Opin. 2011; 27:47–55.

11. SKenealy T, Elley CR, Collins JF, Moyes SA, Metcalf PA, Drury PL. Increased prevalence of albuminuria among non-European peoples with type 2 diabetes. Nephrol Dial Transplant. 2012; 27:1840–6.

12. SYoung BA, Katon WJ, Von Korff M, Simon GE, Lin EH, Ciechanowski PS, Bush T, Oliver M, Ludman EJ, Boyko EJ. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol. 2005; 16:219–28.

13. SAdler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003; 63:225–32.

14. SRetnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006; 55:1832–9.

15. SGrace B, Clayton P, McDonald S. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy. Nephrology (Carlton). 2012; 17:76–84.

16. SParving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006; 69:2057–63.